What does APOTEEK HANCOUR do?

APOTEEK HANCOUR is a pharmacy in Anderlecht. Private Limited, started on 1 January 1968, 1 establishment.

What is the address of APOTEEK HANCOUR?

The registered office of APOTEEK HANCOUR is located at Marie Curiesquare 30, 1070 Anderlecht.

Is APOTEEK HANCOUR still active?

Yes. According to the CBE (31 October 2026) APOTEEK HANCOUR is active, legal situation “Normale toestand”, started on 1 January 1968.

Is APOTEEK HANCOUR registered on Peppol?

Yes, APOTEEK HANCOUR is registered on the Peppol network with ID 0208:0404302136.

What is the enterprise number of APOTEEK HANCOUR?

The enterprise number of APOTEEK HANCOUR is BE0404302136.

When was APOTEEK HANCOUR founded?

APOTEEK HANCOUR was founded on 1 January 1968.

Who are the directors of APOTEEK HANCOUR?

According to the 2025 annual accounts, the directors of APOTEEK HANCOUR are: Hancour Pharmaservice BV.

Is APOTEEK HANCOUR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 January 1968; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTEEK HANCOUR make in 2025?

APOTEEK HANCOUR posted a profit after taxes of € 76,029 in financial year 2025.

What is the revenue of APOTEEK HANCOUR?

As a small company, APOTEEK HANCOUR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 133,498.

APOTEEK HANCOUR (Private Limited) - Anderlecht

Dossier APOTEEK HANCOUR, printed on 31 October 2026 from databakkes.be/en/0404302136/apoteek-hancour. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

15 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

APOTEEK HANCOUR from Anderlecht, company number BE0404302136, closed financial year 2025 with a result of € 76,029 after tax. For that financial year APOTEEK HANCOUR recorded a gross margin of € 133,498 and equity of € 102,272. Compared with financial year 2024, the result moved from € 91,323 to € 76,029. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on March 13, 2026.

What it is worth Growing

€ 102,272

▲ 290% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 76,029

▼ 17% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 49,164

▼ 15% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 83,522.

People and assets in 2025

Vehicles and equipment

€ 753

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 64,182

▼ 35% vs 2024

€ 15,330 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 46,917

▲ 44% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 15,556

▼ 52% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 147,307 Gross margin 2022: € 147,307 First fiscal year in the series	€ 114,307 Gross margin 2023: € 114,307 ▼ 22% vs 2022 (€ 147,307) Unfavourable step	€ 143,942 Gross margin 2024: € 143,942 ▲ 26% vs 2023 (€ 114,307) Favourable step	€ 133,498 Gross margin 2025: € 133,498 ▼ 7% vs 2024 (€ 143,942) Unfavourable step	▼ 7%
Profit after taxes	€ 87,464 Profit after taxes 2022: € 87,464 First fiscal year in the series	€ 62,851 Profit after taxes 2023: € 62,851 ▼ 28% vs 2022 (€ 87,464) Unfavourable step	€ 91,323 Profit after taxes 2024: € 91,323 ▲ 45% vs 2023 (€ 62,851) Favourable step	€ 76,029 Profit after taxes 2025: € 76,029 ▼ 17% vs 2024 (€ 91,323) Unfavourable step	▼ 17%
Equity	€ 22,070 Equity 2022: € 22,070 First fiscal year in the series	€ 24,921 Equity 2023: € 24,921 ▲ 13% vs 2022 (€ 22,070) Favourable step	€ 26,244 Equity 2024: € 26,244 ▲ 5% vs 2023 (€ 24,921) Favourable step	€ 102,272 Equity 2025: € 102,272 ▲ 290% vs 2024 (€ 26,244) Favourable step	▲ 290%
Total debts	€ 433,564 Total debts 2022: € 433,564 First fiscal year in the series	€ 356,393 Total debts 2023: € 356,393 ▼ 18% vs 2022 (€ 433,564) Favourable step	€ 399,611 Total debts 2024: € 399,611 ▲ 12% vs 2023 (€ 356,393) Unfavourable step	€ 252,387 Total debts 2025: € 252,387 ▼ 37% vs 2024 (€ 399,611) Favourable step	▼ 37%
Cash	€ 48,125 Cash 2022: € 48,125 First fiscal year in the series	€ 32,631 Cash 2023: € 32,631 ▼ 32% vs 2022 (€ 48,125) Unfavourable step	€ 57,816 Cash 2024: € 57,816 ▲ 77% vs 2023 (€ 32,631) Favourable step	€ 49,164 Cash 2025: € 49,164 ▼ 15% vs 2024 (€ 57,816) Unfavourable step	▼ 15%
Retained profit	€ 3,320 Retained profit 2022: € 3,320 First fiscal year in the series	€ 6,171 Retained profit 2023: € 6,171 ▲ 86% vs 2022 (€ 3,320) Favourable step	€ 7,494 Retained profit 2024: € 7,494 ▲ 21% vs 2023 (€ 6,171) Favourable step	€ 83,522 Retained profit 2025: € 83,522 ▲ € 76,029 vs 2024 (€ 7,494) Favourable step	▲ € 76,029
Dividend	€ 87,000 Dividend 2022: € 87,000 First fiscal year in the series	€ 60,000 Dividend 2023: € 60,000 ▼ 31% vs 2022 (€ 87,000) Unchanged	€ 90,000 Dividend 2024: € 90,000 ▲ 50% vs 2023 (€ 60,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 90,000) Unchanged	▼ 100%
Bank debt	€ 139,370 Bank debt 2022: € 139,370 First fiscal year in the series	€ 107,341 Bank debt 2023: € 107,341 ▼ 23% vs 2022 (€ 139,370) Favourable step	€ 99,045 Bank debt 2024: € 99,045 ▼ 8% vs 2023 (€ 107,341) Favourable step	€ 64,182 Bank debt 2025: € 64,182 ▼ 35% vs 2024 (€ 99,045) Favourable step	▼ 35%
Balance sheet total	€ 455,634 Balance sheet total 2022: € 455,634 First fiscal year in the series	€ 381,314 Balance sheet total 2023: € 381,314 ▼ 16% vs 2022 (€ 455,634) Unchanged	€ 425,855 Balance sheet total 2024: € 425,855 ▲ 12% vs 2023 (€ 381,314) Unchanged	€ 354,659 Balance sheet total 2025: € 354,659 ▼ 17% vs 2024 (€ 425,855) Unchanged	▼ 17%

Key figures of APOTEEK HANCOUR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTEEK HANCOUR?

What happened at APOTEEK HANCOUR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 13, 2026 New annual accounts for financial year 2025: profit of € 76,029 (▼ 17% vs 2024). Source: NBB ↗
Jan 1, 1968 Start of the company according to the CBE. KBO
Jul 1, 1961 New establishment in Mortsel. KBO

In short

From € 87,464 profit in 2022 to € 76,029 profit in 2025.

Paid € 113,394 in corporate taxes since 2022.

Best year ever: 2024, with € 91,323 profit.

Paid out € 237,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

HANCOUR PHARMASERVICE 100%

The stake of HANCOUR PHARMASERVICE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTEEK HANCOUR

Behind APOTEEK HANCOUR is Hancour Pharmaservice BV. The shares are held by HANCOUR PHARMASERVICE (100%).

Directors

According to the 2025 annual accounts

Hancour Pharmaservice BV

Director · represented by Benedikte Courtin

Shareholders

HANCOUR PHARMASERVICE

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Marie Curiesquare 30

1070 Anderlecht

2.004.934.471

Antwerpsestraat 300

2640 Mortsel

Active since 1 July 1961

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 15 companies are registered at this address.

All companies at this address →

MULTIPHARMA GROUP

Office des sociétés coopératives de grossistes pharmaceutiques et de pharmacies - Vereniging van coöperatieve vennootschappen van farmaceutische groothandelaars en apotheken

Apoteek Jespers - Cuijpers

€ 113,239 gross margin · 2025

APOTEEK P. Sergeant

€ 10,336 gross margin · 2025

APOTHEEK VANDYCK

€ 1,703 gross margin · 2025

+10 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0404.302.136

VAT number

BE 0404.302.136

Registered office

Marie Curiesquare 30, 1070 Anderlecht

Names & denominations

APOTEEK HANCOUR

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 January 1968

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTEEK HANCOUR

Warning lights

Financials

What happened to APOTEEK HANCOUR?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions